On September 30, 2022, the Massachusetts Bar Association held its annual Health Law Conference. During the conference, which focused on the rapidly evolving area of telehealth law, Mr. Sheehan spoke about issues concerning telehealth coverage issues developing in the context of commercial insurance. For more information about the conference, and to find out how to […]
Judge Contreras of the federal District Court for the District of Columbia has vacated the Department of Health and Human Service’s rule cutting Medicare reimbursement to 340B hospitals for outpatient drugs for 2022. This means that 340B hospitals will be paid at the default Medicare rate of Average Sales Price plus 6% for these drugs
FEDERAL COURT ENDS CUTS TO PAYMENTS TO 340B HOSPITALS FOR OUTPATIENT DRUGS FOR 2022 Read More »
Jerome A. (Buddy) Cooper received a well-deserved recognition of being admitted to the Alabama Lawyers Hall of Fame. After serving as Justice Black’s first law clerk, Buddy was one of the founding partners of Cooper, Mitch & Black, which was the law firm where Joe Whatley began his law practice. Buddy was a great lawyer
BUDDY COOPER ADMITTED TO ALABAMA LAWYERS HALL OF FAME Read More »
Truvada is a blockbuster drug used to treat and prevent HIV infection. Manufactured by Gilead Sciences, Truvada is a combination of two patented drugs in one pill. Several generic drug manufacturers challenged the validity of the patents on these drugs, especially one called emtricitabine. Gilead settled all of this litigation, including a case it filed
JUDGE RULES THAT CLAIMS RELATING TO TRUVADA CAN PROCEED Read More »
On August 19, 2022, the Departments of Health and Human Services, Labor, and the Treasury (“the Departments”) issued their long-awaited Final Rules (“Final Rules”) under the No Surprises Act (“the Act”). The Final Rules significantly changed the previously issued Interim Final Rules in ways that should improve the transparency and fairness of the process for
Late Friday a federal court in San Francisco allowed a case against subsidiaries of CVS Health Corporation brought by HIV-positive “John Doe” plaintiffs to proceed, denying CVS’s motion to dismiss the case. This ruling comes on the heels of CVS’s abrupt dismissal late last year of its appeal to the United States Supreme Court of
CVS Health has reported strong second quarter profits and revenues, beating analysts’ expectations. CVS reported second quarter profits of $2.95 billion, up from $2.8 billion for the prior year quarter. This brings its profits for the first half of the year to $5.3 billion. CVS also reported strong revenues of $80.6 billion for the second
CVS HEALTH REPORTS STRONG SECOND QUARTER PROFITS, BEATING ANALYSTS’ EXPECTATIONS Read More »
New York’s Attorney General, Letitia James, has sued CVS Health Corp., alleging that it violated New York’s antitrust laws and abused its market power by illegally requiring safety net hospitals that contract with CVS pharmacies for dispensing 340B outpatient drugs to exclusively use CVS’s subsidiary Wellpartner as their Third Party Administrator (“TPA”) for the 340B
Humana, Inc. has reported strong second quarter profits of $696 million, bringing its profits for the first half of the year to $1.6 billion, an increase of 14.8% from the first half of 2021. Humana also reported strong revenues of $23.7 billion for the second quarter, an increase of 14.6% from the second quarter of
Anthem, Inc., now known as Elevance Health, reported strong profits of $2.4 billion for the second quarter of 2022, an increase of 13.7% over the prior year quarter. Anthem’s operating revenues were also sharply up, growing 15.6% over the prior year quarter to $38.5 billion. Anthem’s adjusted net income was $8.04 per share, beating analysists’